The IVD testing plays a significant role in clinical decision-making. Over the years, IVD quality control products and procedures have become mandatory in accredited clinical or medical laboratories. To ensure technological competitiveness, companies are continuously launching innovative and advanced quality control products in the market for a variety of applications. The applications of IVD quality control products have also widened over the years, with a number of quality controls currently available in the market for clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation, and microbiology.
According to the new market research report In Vitro Diagnostics Quality Control Market is projected to reach $1.4 billion by 2026, at a CAGR of 5.3% during the forecast period.
The growth of the Quality Control in IVD Market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, increasing adoption of and POC instruments in developed regions, rising demand for external quality assessment programs and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries.
Some of the key players in the In Vitro Diagnostics (IVD) Quality Control Market include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), and Abbott Laboratories (US).
Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), Helena Laboratories Corporation (US), Quidel Corporation (US), ZeptoMetrix Corporation (US), Qnostics (UK), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Bio-Techne Corporation (US), Microbiologics (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582